• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

庇护蛋白复合体基因:癌症中的预后与治疗易损性

Shelterin complex gene: Prognosis and therapeutic vulnerability in cancer.

作者信息

Bhari Vikas Kumar, Kumar Durgesh, Kumar Surendra, Mishra Rajeev

机构信息

Department of Biosciences, Manipal University Jaipur, Rajasthan, India.

Department of Physiology, Government Medical College, Kannauj, Uttar Pradesh, India.

出版信息

Biochem Biophys Rep. 2021 Feb 2;26:100937. doi: 10.1016/j.bbrep.2021.100937. eCollection 2021 Jul.

DOI:10.1016/j.bbrep.2021.100937
PMID:33553693
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7859307/
Abstract

Telomere encompasses a (TTAGGG)n tandem repeats, and its dysfunction has emerged as the epicenter of driving carcinogenesis by promoting genetic instability. Indeed, they play an essential role in stabilizing chromosomes and therefore protecting them from end-to-end fusion and DNA degradation. Telomere length homeostasis is regulated by several key players including shelterin complex genes, telomerase, and various other regulators. Targeting these regulatory players can be a good approach to combat cancer as telomere length is increasingly correlated with cancer initiation and progression. In this review, we have aimed to describe the telomere length regulator's role in prognostic significance and important drug targets in breast cancer. Moreover, we also assessed alteration in telomeric function by various telomere length regulators and compares this to the regulatory mechanisms that can be associated with clinical biomarkers in cancer. Using publicly available software we summarized mutational and CpG island prediction analysis of the TERT gene breast cancer patient database. Studies have reported that the TERT gene has prognostic significance in breast cancer progression however mechanistic approaches are not defined yet. Interestingly, we reported using the UCSC Xena web-based tool, we confirmed a positive correlation of shelterin complex genes TERF1 and TERF2 in recurrent free survival, indicating the critical role of these genes in breast cancer prognosis. Moreover, the epigenetic landscape of DNA damage repair genes in different breast cancer subtypes also being analyzed using the UCSC Xena database. Together, these datasets provide a comprehensive resource for shelterin complex gene profiles and define epigenetic landscapes of DNA damage repair genes which reveals the key role of shelterin complex genes in breast cancer with the potential to identify novel and actionable targets for treatment.

摘要

端粒包含(TTAGGG)n串联重复序列,其功能障碍已成为通过促进基因不稳定驱动致癌作用的核心。事实上,它们在稳定染色体方面发挥着至关重要的作用,从而保护染色体免于端对端融合和DNA降解。端粒长度稳态由包括端粒保护蛋白复合体基因、端粒酶和各种其他调节因子在内的几个关键参与者调节。由于端粒长度与癌症的发生和进展越来越相关,针对这些调节参与者可能是对抗癌症的一种好方法。在这篇综述中,我们旨在描述端粒长度调节因子在乳腺癌预后意义和重要药物靶点中的作用。此外,我们还评估了各种端粒长度调节因子对端粒功能的改变,并将其与癌症中可能与临床生物标志物相关的调节机制进行比较。使用公开可用的软件,我们总结了乳腺癌患者数据库中TERT基因的突变和CpG岛预测分析。研究报告称,TERT基因在乳腺癌进展中具有预后意义,但尚未确定其机制方法。有趣的是,我们报告使用基于UCSC Xena网络的工具,证实了端粒保护蛋白复合体基因TERF1和TERF2在无复发生存中的正相关,表明这些基因在乳腺癌预后中的关键作用。此外,还使用UCSC Xena数据库分析了不同乳腺癌亚型中DNA损伤修复基因的表观遗传格局。总之,这些数据集为端粒保护蛋白复合体基因谱提供了全面的资源,并定义了DNA损伤修复基因的表观遗传格局,揭示了端粒保护蛋白复合体基因在乳腺癌中的关键作用,有可能识别新的可操作治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1214/7859307/2001a018ba2d/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1214/7859307/dca4a3ff1294/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1214/7859307/c2bebc1373f8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1214/7859307/67dae2b3a8d7/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1214/7859307/42d720a400da/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1214/7859307/f226145dff7a/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1214/7859307/2001a018ba2d/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1214/7859307/dca4a3ff1294/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1214/7859307/c2bebc1373f8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1214/7859307/67dae2b3a8d7/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1214/7859307/42d720a400da/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1214/7859307/f226145dff7a/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1214/7859307/2001a018ba2d/gr6.jpg

相似文献

1
Shelterin complex gene: Prognosis and therapeutic vulnerability in cancer.庇护蛋白复合体基因:癌症中的预后与治疗易损性
Biochem Biophys Rep. 2021 Feb 2;26:100937. doi: 10.1016/j.bbrep.2021.100937. eCollection 2021 Jul.
2
The effect of chemotherapeutic agents on telomere length maintenance in breast cancer cell lines.化疗药物对乳腺癌细胞系中端粒长度维持的影响。
Breast Cancer Res Treat. 2014 Jun;145(3):581-91. doi: 10.1007/s10549-014-2975-x. Epub 2014 May 8.
3
Identifying the biomarker potential of telomerase activity and shelterin complex molecule, telomeric repeat binding factor 2 (TERF2), in multiple myeloma.确定端粒酶活性和保护素复合体分子端粒重复结合因子2(TERF2)在多发性骨髓瘤中的生物标志物潜力。
Leuk Lymphoma. 2018 Jul;59(7):1677-1689. doi: 10.1080/10428194.2017.1387915. Epub 2017 Oct 18.
4
Upregulation of shelterin and CST genes and longer telomeres are associated with unfavorable prognostic characteristics in prostate cancer.抑癌基因 shelterin 和 CST 表达上调与端粒延长与前列腺癌不良预后相关。
Cancer Genet. 2024 Jun;284-285:20-29. doi: 10.1016/j.cancergen.2024.03.006. Epub 2024 Mar 16.
5
Differential Expression of Non-Shelterin Genes Associated with High Telomerase Levels and Telomere Shortening in Plasma Cell Disorders.浆细胞疾病中与端粒酶水平升高和端粒缩短相关的非庇护蛋白基因的差异表达
PLoS One. 2015 Sep 14;10(9):e0137972. doi: 10.1371/journal.pone.0137972. eCollection 2015.
6
Structural biology of telomeres and telomerase.端粒和端粒酶的结构生物学。
Cell Mol Life Sci. 2020 Jan;77(1):61-79. doi: 10.1007/s00018-019-03369-x. Epub 2019 Nov 14.
7
Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing "stemness"-related markers.端粒长度、TERT 和具有“干性”相关标志物表达的肝细胞癌中的庇护素复合物蛋白。
J Hepatol. 2013 Oct;59(4):746-52. doi: 10.1016/j.jhep.2013.05.011. Epub 2013 May 14.
8
Shelterin: the protein complex that shapes and safeguards human telomeres.端粒保护蛋白复合体:塑造并保护人类端粒的蛋白质复合体。
Genes Dev. 2005 Sep 15;19(18):2100-10. doi: 10.1101/gad.1346005.
9
Structural Features of Nucleoprotein CST/Shelterin Complex Involved in the Telomere Maintenance and Its Association with Disease Mutations.参与端粒维持的核蛋白 CST/庇护素复合物的结构特征及其与疾病突变的关联。
Cells. 2020 Feb 4;9(2):359. doi: 10.3390/cells9020359.
10
ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosis.新辅助化疗治疗的乳腺肿瘤中ERCC1和端粒状态及其与患者预后的关联
J Pathol Clin Res. 2016 Jul 13;2(4):234-246. doi: 10.1002/cjp2.52. eCollection 2016 Oct.

引用本文的文献

1
Low-power red laser and blue LED modulate telomere maintenance and length in human breast cancer cells.低强度红光激光和蓝光 LED 调节人乳腺癌细胞端粒维持和长度。
Lasers Med Sci. 2024 Oct 7;39(1):248. doi: 10.1007/s10103-024-04194-w.
2
Obesity-Senescence-Breast Cancer: Clinical Presentation of a Common Unfortunate Cycle.肥胖-衰老-乳腺癌:一个常见不幸循环的临床表现。
Adv Exp Med Biol. 2024;1460:821-850. doi: 10.1007/978-3-031-63657-8_27.
3
Association of Obesity with Telomere Length in Human Sperm.人类精子中肥胖与端粒长度的关联

本文引用的文献

1
Composition and Function of Telomerase-A Polymerase Associated with the Origin of Eukaryotes.端粒酶的组成和功能-与真核生物起源相关的聚合酶。
Biomolecules. 2020 Oct 8;10(10):1425. doi: 10.3390/biom10101425.
2
Targeting telomerase for its advent in cancer therapeutics.针对端粒酶在癌症治疗中的新作用。
Med Res Rev. 2020 Sep;40(5):1871-1919. doi: 10.1002/med.21674. Epub 2020 May 11.
3
Diagnostic performance of peripheral leukocyte telomere G-tail length for detecting breast cancer.外周血白细胞端粒 G 尾长度检测乳腺癌的诊断性能。
J Clin Med. 2024 Apr 8;13(7):2150. doi: 10.3390/jcm13072150.
4
Effects of HSV-G47Δ Oncolytic Virus on Telomerase and Telomere Length Alterations in Glioblastoma Multiforme Cancer Stem Cells Under Hypoxia and Normoxia Conditions.HSV-G47Δ 溶瘤病毒对缺氧和常氧条件下胶质母细胞瘤多形性癌细胞干细胞中端粒酶和端粒长度改变的影响。
Curr Cancer Drug Targets. 2024;24(12):1262-1274. doi: 10.2174/0115680096274769240115165344.
5
The Influence of Telomere-Related Gene Variants, Serum Levels, and Relative Leukocyte Telomere Length in Pituitary Adenoma Occurrence and Recurrence.端粒相关基因变异、血清水平及相对白细胞端粒长度对垂体腺瘤发生和复发的影响
Cancers (Basel). 2024 Feb 2;16(3):643. doi: 10.3390/cancers16030643.
6
Deciphering Treg cell roles in esophageal squamous cell carcinoma: a comprehensive prognostic and immunotherapeutic analysis.解析调节性T细胞在食管鳞状细胞癌中的作用:一项全面的预后和免疫治疗分析。
Front Mol Biosci. 2023 Sep 28;10:1277530. doi: 10.3389/fmolb.2023.1277530. eCollection 2023.
7
Associations between telomere attrition, genetic variants in telomere maintenance genes, and non-small cell lung cancer risk in the Jammu and Kashmir population of North India.印度北部查谟和克什米尔地区人群中端粒损耗、端粒维持基因遗传变异与非小细胞肺癌风险的相关性。
BMC Cancer. 2023 Sep 18;23(1):874. doi: 10.1186/s12885-023-11387-z.
8
The new world of RNA diagnostics and therapeutics.RNA 诊断和治疗的新世界。
J Exp Clin Cancer Res. 2023 Jul 29;42(1):189. doi: 10.1186/s13046-023-02752-8.
9
Deciphering the Functions of Telomerase Reverse Transcriptase in Head and Neck Cancer.解析端粒酶逆转录酶在头颈癌中的功能
Biomedicines. 2023 Feb 24;11(3):691. doi: 10.3390/biomedicines11030691.
10
MiR-182-3p targets TRF2 and impairs tumor growth of triple-negative breast cancer.miR-182-3p 靶向 TRF2 并抑制三阴性乳腺癌的肿瘤生长。
EMBO Mol Med. 2023 Jan 11;15(1):e16033. doi: 10.15252/emmm.202216033. Epub 2022 Nov 25.
Cancer Sci. 2020 May;111(5):1856-1861. doi: 10.1111/cas.14378. Epub 2020 Apr 6.
4
, a promoter of CNS malignancies.中枢神经系统恶性肿瘤的一个促进因子。 (你提供的原文不完整,推测可能是这样的翻译,完整准确的翻译需结合更完整的句子语境)
Neurooncol Adv. 2020 Jan-Dec;2(1):vdaa025. doi: 10.1093/noajnl/vdaa025. Epub 2020 Feb 28.
5
Therapeutic strategies for targeting telomerase in cancer.针对癌症端粒酶的治疗策略。
Med Res Rev. 2020 Mar;40(2):532-585. doi: 10.1002/med.21626. Epub 2019 Jul 30.
6
Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players.人类癌症中端粒酶转录和端粒酶活性激活的机制:旧演员和新角色。
Oncogene. 2019 Aug;38(34):6172-6183. doi: 10.1038/s41388-019-0872-9. Epub 2019 Jul 8.
7
Multiple cancer pathways regulate telomere protection.多种癌症途径调节端粒保护。
EMBO Mol Med. 2019 Jul;11(7):e10292. doi: 10.15252/emmm.201910292. Epub 2019 Jun 13.
8
Telomerase inhibitor MST-312 induces apoptosis of multiple myeloma cells and down-regulation of anti-apoptotic, proliferative and inflammatory genes.端粒酶抑制剂 MST-312 诱导多发性骨髓瘤细胞凋亡及下调抗凋亡、增殖和炎症基因。
Life Sci. 2019 Jul 1;228:66-71. doi: 10.1016/j.lfs.2019.04.060. Epub 2019 Apr 25.
9
Long-term in vitro treatment with telomerase inhibitor MST-312 induces resistance by selecting long telomeres cells.长期的端粒酶抑制剂 MST-312 的体外处理通过选择长端粒细胞诱导耐药性。
Cell Biochem Funct. 2019 Jun;37(4):273-280. doi: 10.1002/cbf.3398. Epub 2019 Apr 23.
10
Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis.端粒的非经典延长(ALT)影响软组织肉瘤的生存:系统评价与荟萃分析。
BMC Cancer. 2019 Mar 14;19(1):232. doi: 10.1186/s12885-019-5424-8.